Giuseppe Roscilli

Chief Technology Officer and Director

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Giuseppe Roscilli is the Chief Technology Officer and Director at Takis Srl in Italy. His research focuses on the tumor microenvironment, the development of COVID-19 vaccines, and the characterization of monoclonal antibodies. Recent publications include advancements in genetic vaccines and the exploration of new heparanase inhibitors.

Articles (6)

Year:

2024

Year:

2024

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Luigi Aurisicchio

Chief Executive Officer

ITALY

View details

Fabio Palombo

Chief scientific officer

Neomatrix biotech

ITALY

View details

Luca G. Guidotti

Full Professor

Università Vita Salute San Raffaele

ITALY

View details

Rüdiger Martin Groß

University Hospital Ulm

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giuseppe Roscilli

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein

On-chip recapitulation of the tumor microenvironment: A decade of progress

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.

Are Genetic Vaccines the Right Weapon against COVID-19?

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines

New classes of potent heparanase inhibitors from ligand-based virtual screening

Collaborators (4)

Luigi Aurisicchio

Fabio Palombo

Luca G. Guidotti

Rüdiger Martin Groß

Make your next move.